Continuous Manufacturing of Drug Product (20of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 26:11 4 years ago 3 689 Скачать Далее
Case Studies: Continuous Manufacturing of Drug Substance (21of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 18:17 4 years ago 947 Скачать Далее
Policy Considerations for Continuous Manufacturing (19of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 20:53 4 years ago 387 Скачать Далее
End-to-end Integrated Continuous Manufacturing (25of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 20:18 4 years ago 194 Скачать Далее
Application Manufacturing Assessment (4of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 26:22 4 years ago 221 Скачать Далее
Emerging Technology Program (18of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 18:30 4 years ago 326 Скачать Далее
Continuous Manufacturing with a Generic Perspective (25of28) Generic Drugs Forum – Apr. 3-4, 2019 U.S. Food and Drug Administration 25:22 4 years ago 507 Скачать Далее
Quality Considerations for Continuous Manufacturing of APIs U.S. Food and Drug Administration 20:20 3 years ago 1 695 Скачать Далее
The Importance of Quality in Our Medicines (2of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 19:09 4 years ago 260 Скачать Далее
Panel Questions and Discussion (22of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 11:28 4 years ago 86 Скачать Далее
Pharmaceutical Quality Surveillance Program (14of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 22:17 4 years ago 222 Скачать Далее
Pharmaceutical Continuous Manufacturing is a Promising and Much-Needed Solution | USP US Pharmacopeia 2:13 2 years ago 1 261 Скачать Далее
Policy Initiatives for Pharmaceutical Quality (5of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 19:34 4 years ago 114 Скачать Далее
Keynote: CDER’s Commitment to Pharmaceutical Quality (1of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 16:13 4 years ago 599 Скачать Далее
Quality Assessment of BLAs, NDAs, and ANDAs (3of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 25:06 4 years ago 624 Скачать Далее
FDA’s Quality Assessment and Knowledge Management - KASA (11of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 23:35 4 years ago 3 416 Скачать Далее
CONTINUUS Pharmaceuticals | Integrated Continuous Manufacturing (ICM) IMA Group 14:46 2 years ago 848 Скачать Далее
Quality-Related Compliance Actions and Trends (15of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 20:08 4 years ago 176 Скачать Далее
Quality Considerations for Transition Biological Products (32of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 15:58 4 years ago 452 Скачать Далее
Quality Metrics, Quality Culture, and Data-Driven Decisions (16of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration 20:57 4 years ago 954 Скачать Далее
